This inventor holds 1 USPTO granted patent. Top assignee: Mellitech. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Martin Ohsten: Innovator in Pharmaceutical Compositions
Introduction
Martin Ohsten is a notable inventor based in Ruy Montceau, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address insulin regulation issues.
Latest Patents
Ohsten holds a patent for [1,5]-diazocin derivatives. This invention relates to compounds of formula (I), which are utilized in pharmaceutical compositions and medicaments. The primary focus of this patent is to treat diseases associated with insulin regulation problems, such as diabetes. The invention also encompasses methods for treating or preventing such diseases.
Career Highlights
Martin Ohsten is associated with Mellitech, where he applies his expertise in pharmaceutical innovations. His work has led to advancements in the treatment of diabetes and related conditions.
Collaborations
Ohsten has collaborated with notable colleagues, including Didier Roche and Fabrice Chimienti, contributing to the innovative environment at Mellitech.
Conclusion
Martin Ohsten's work in developing pharmaceutical compositions showcases his commitment to addressing critical health issues. His contributions are vital in the ongoing fight against diabetes and similar diseases.